DEXTROSE INJECTION USP
PFIZER CANADA ULC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of DEXTROSE INJECTION USP in Canada?
Yes. DEXTROSE INJECTION USP 500MG has an active shortage reported to Health Canada (last updated October 27, 2026).
Why is DEXTROSE INJECTION USP not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will DEXTROSE INJECTION USP be available again?
The manufacturer's estimated resolution date is February 15, 2027. This is an estimate and can change; follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
DEXTROSE INJECTION USP
ICU MEDICAL CANADA INC
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Health Canada classes this as a Tier 3 shortage, its highest-impact category. If you rely on this medication, talk to your pharmacist or care team now rather than waiting for your supply to run low. This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.
⚠ Possible Recall or Safety Alert
Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.
5% DEXTROSE INJECTION, USP
5% DEXTROSE INJECTION, USP: Solution bags may be leaking in affected lots.
Highest health risk
Possible match — not confirmed
5% Dextrose Injection, USP
5% Dextrose Injection, USP: Solution bags may be leaking in affected lots.
Highest health risk
Possible match — not confirmed
Dextrose 50 mg/mL Injection USP
Dextrose 50 mg/mL Injection; Out of Specification
Moderate health risk
Possible match — not confirmed
DIN
02468514
Strength
500MG
Dosage Form
SOLUTION
Route
INTRAVENOUS
Compare with another product →
Product Monograph
Product monograph is not available from Health Canada
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Disruption of the manufacture of the drug.
Disruption of the manufacture of the drug.
Business reasons
Other Products from PFIZER CANADA ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
40MG · DIN 02511053
40MG · DIN 02511045
20MG · DIN 02511061
DIN 02544040
5MG · DIN 01947664
10MG · DIN 01947672
20MG · DIN 01947680
40MG · DIN 01947699
DIN 02237367
DIN 02237368
DIN 02237369
50MG · DIN 02401347